PL3174891T3 - Krystaliczna postać rybozydu nikotynamidu - Google Patents
Krystaliczna postać rybozydu nikotynamiduInfo
- Publication number
- PL3174891T3 PL3174891T3 PL15825253T PL15825253T PL3174891T3 PL 3174891 T3 PL3174891 T3 PL 3174891T3 PL 15825253 T PL15825253 T PL 15825253T PL 15825253 T PL15825253 T PL 15825253T PL 3174891 T3 PL3174891 T3 PL 3174891T3
- Authority
- PL
- Poland
- Prior art keywords
- crystalline form
- nicotinamide riboside
- riboside
- nicotinamide
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462028702P | 2014-07-24 | 2014-07-24 | |
PCT/US2015/041956 WO2016014927A2 (en) | 2014-07-24 | 2015-07-24 | Crystalline form of nicotinamide riboside |
EP15825253.6A EP3174891B1 (en) | 2014-07-24 | 2015-07-24 | Crystalline form of nicotinamide riboside |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3174891T3 true PL3174891T3 (pl) | 2020-08-10 |
Family
ID=55163976
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15825253T PL3174891T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać rybozydu nikotynamidu |
PL20153772T PL3670522T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać chlorku rybozydu nikotynamidu |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20153772T PL3670522T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać chlorku rybozydu nikotynamidu |
Country Status (7)
Country | Link |
---|---|
US (2) | US10323058B2 (pl) |
EP (2) | EP3670522B1 (pl) |
CN (1) | CN106715454B (pl) |
CA (1) | CA2956163C (pl) |
ES (2) | ES2776395T3 (pl) |
PL (2) | PL3174891T3 (pl) |
WO (1) | WO2016014927A2 (pl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10189872B2 (en) * | 2015-03-09 | 2019-01-29 | W. R. Grace & Co.-Conn | Crystalline form of nicotinamide riboside |
CA2994553C (en) | 2015-08-05 | 2022-08-30 | Metro International Biotech, Llc | Nicotinamide mononucleotide derivatives and their uses |
GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
AU2017232930B2 (en) | 2016-03-16 | 2021-03-25 | ChromaDex Inc. | B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof |
WO2017218580A1 (en) | 2016-06-14 | 2017-12-21 | Rejuvenation Therapeutics Corporation | Synthetic methods for the preparation of nicotinamide riboside and related compounds |
EP3538099A4 (en) | 2016-11-11 | 2020-06-17 | The Queen's University of Belfast | EFFICIENT AND EVOLUTIVE SYNTHESIS OF NICOTINOYLE RIBOSIDES AND NICOTINOYLE RIBOSIDES, THEIR MODIFIED DERIVATIVES, THEIR PHOSPHORYLATED ANALOGS, THEIR CONJUGATES WITH ADENYLYLE DINUCLEOTIDE AND NEW CRISTALLY FORMULATES |
US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
CN110234238B (zh) | 2016-11-29 | 2023-03-28 | 爱荷华大学研究基金会 | Nad前体用于改善母体健康和/或后代健康的用途 |
WO2018236814A2 (en) | 2017-06-19 | 2018-12-27 | Gangadhara Ganapati | NICOTINAMIDE RIBOSID DERIVATIVES AND USES THEREOF |
EP3727400A4 (en) * | 2017-12-22 | 2021-10-20 | Elysium Health, Inc. | CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE |
WO2019152416A1 (en) | 2018-01-30 | 2019-08-08 | Metro International Biotech, Llc | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof |
JP7160946B2 (ja) | 2018-05-18 | 2022-10-25 | エフ.ホフマン-ラ ロシュ アーゲー | (チオ)ニコチンアミドリボフラノシド塩および組成物、製造方法、およびそれらの使用 |
CN108774278A (zh) * | 2018-09-10 | 2018-11-09 | 张洪喜 | 一种制备尼克酰胺核苷盐的方法 |
US11214589B2 (en) | 2018-12-10 | 2022-01-04 | ChromaDex Inc. | Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof |
US11833167B2 (en) | 2018-12-17 | 2023-12-05 | Mitopower Llc | Nicotinyl riboside compounds and their uses |
CA3130704A1 (en) * | 2019-02-21 | 2020-08-27 | ChromaDex Inc. | Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations |
US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
US10618927B1 (en) | 2019-03-22 | 2020-04-14 | Metro International Biotech, Llc | Compositions and methods for modulation of nicotinamide adenine dinucleotide |
CN114423771A (zh) | 2019-07-19 | 2022-04-29 | 生物合成股份公司 | 制备烟酰胺呋喃核糖苷盐的方法、烟酰胺呋喃核糖苷盐本身及其用途 |
CN111808156A (zh) * | 2020-07-15 | 2020-10-23 | 许昌远志生物科技有限公司 | 一种β-烟酰胺核糖氯化物的晶型1A、晶型1B及其制备方法 |
JP2024520410A (ja) | 2021-05-27 | 2024-05-24 | メトロ インターナショナル バイオテック,エルエルシー | ニコチン酸モノヌクレオチド及びそのエステルの結晶性固体並びに作製及び使用方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1190080A (en) | 1966-08-08 | 1970-04-29 | Kyowa Hakko Kogyo Company Ltd | Process for producing Nicotinamide Adenine Dinucleotide |
US3728111A (en) | 1971-09-21 | 1973-04-17 | Asea Ab | Method of manufacturing billets from powder |
ES2264197T3 (es) | 1997-02-06 | 2006-12-16 | Inspire Pharmaceuticals, Inc. | Dinucleotidos y sus usos. |
GB9712370D0 (en) | 1997-06-14 | 1997-08-13 | Aepact Ltd | Therapeutic systems |
WO2002048165A2 (en) | 2000-12-15 | 2002-06-20 | Pharmasset Ltd. | Antiviral agents for treatment of flaviviridae infections |
US7179791B2 (en) | 2001-01-11 | 2007-02-20 | Duke University | Inhibiting GS-FDH to modulate NO bioactivity |
US7977049B2 (en) * | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
US20050020587A1 (en) * | 2003-07-25 | 2005-01-27 | Pfizer Inc | Nicotinamide derivatives useful as PDE4 inhibitors |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
US8114626B2 (en) | 2004-02-10 | 2012-02-14 | Trustees Of Dartmouth College | Yeast strain and method for using the same to produce nicotinamide riboside |
JP2007521835A (ja) | 2004-02-10 | 2007-08-09 | トラスティーズ・オブ・ダートマウス・カレッジ | ニコチンアミドリボシドキナーゼ組成物およびそれらの使用方法 |
JP2008501343A (ja) | 2004-06-04 | 2008-01-24 | ワシントン・ユニバーシティ | 神経障害を治療するための方法および組成物 |
UA94901C2 (ru) | 2005-02-18 | 2011-06-25 | Астразенека Аб | Антибактериальные производные пиперидина |
WO2006105440A2 (en) * | 2005-03-30 | 2006-10-05 | Sirtris Pharmaceuticals, Inc. | Nicotinamide riboside and analogues thereof |
US20070149466A1 (en) | 2005-07-07 | 2007-06-28 | Michael Milburn | Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
US8106184B2 (en) * | 2005-11-18 | 2012-01-31 | Cornell University | Nicotinoyl riboside compositions and methods of use |
AU2006339607A1 (en) | 2005-12-02 | 2007-09-13 | Sirtris Pharmaceuticals, Inc. | Modulators of Cdc2-like kinases (Clks) and methods of use thereof |
WO2007136744A1 (en) | 2006-05-19 | 2007-11-29 | The Johns Hopkins University | Crystal structure of a substrate complex of nampt/pbef/visfatin |
CA2672373C (en) * | 2006-12-19 | 2011-08-30 | Pfizer Products Inc. | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
CA2676609A1 (en) | 2007-01-26 | 2008-07-31 | Washington University | Methods and compositions for treating neuropathies |
WO2009153721A1 (en) * | 2008-06-18 | 2009-12-23 | Pfizer Limited | Nicotinamide derivatives |
US20100015072A1 (en) | 2008-06-30 | 2010-01-21 | Christopher Polla | Topical Compositions Comprising Isonicotinamide |
EP2520581A1 (en) | 2008-08-06 | 2012-11-07 | Sicor, Inc. | Method for the determination the purity of 5-Azacytidine |
WO2011005289A2 (en) | 2009-06-23 | 2011-01-13 | President And Fellows Of Harvard College | Methods and kits for measuring enzyme activity |
NZ598290A (en) | 2009-07-24 | 2014-12-24 | Amazentis Sa | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders |
US8507251B2 (en) | 2009-09-28 | 2013-08-13 | Robert J. Greenstein | Medium and method for culturing Mycobacterium avium subspecies paratuberculosis |
WO2011081942A1 (en) | 2009-12-14 | 2011-07-07 | Cornell University | Activation and activators of sirt5 |
US20130165398A1 (en) | 2010-03-29 | 2013-06-27 | Paul Hochegger | Concentration-enhancing drink |
JP5663576B2 (ja) | 2010-07-06 | 2015-02-04 | 上西 秀則 | 神経突起伸長剤 |
WO2012114204A2 (en) | 2011-02-15 | 2012-08-30 | Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto | Methods of treating mitochondrial dysfunction |
US20120107888A1 (en) | 2011-02-17 | 2012-05-03 | Qteros, Inc. | Modulation of fermentation products through vitamin supplementation |
US20120328526A1 (en) | 2011-06-27 | 2012-12-27 | University Of Maryland, Baltimore | Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof |
CA2847292A1 (en) | 2011-06-29 | 2013-01-03 | The General Hospital Corporation | Compositions and methods for enhancing bioenergetic status in female germ cells |
CA2840516A1 (en) | 2011-06-29 | 2013-01-03 | President And Fellows Of Harvard College | Small molecule cd38 inhibitors and methods of using same |
US20140256760A1 (en) | 2012-07-09 | 2014-09-11 | Noglo Llc | Reduction or prevention of alcohol reaction with dietary supplements |
EP2869717B8 (en) | 2012-07-09 | 2018-07-25 | NoGlo, Inc. | Prevention of alcohol reaction with dietary supplements |
WO2014014828A1 (en) | 2012-07-16 | 2014-01-23 | Cornell University | Nicotinamide riboside to treat hearing loss |
AU2013329312A1 (en) | 2012-10-09 | 2015-05-28 | Massachusetts Institute Of Technology | Treatment of age-related and mitochondrial diseases by inhibition of HIF-1 alpha function |
WO2014111906A1 (en) | 2013-01-21 | 2014-07-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Bioluminescence imaging of small biomolecules |
CA2902879C (en) | 2013-03-15 | 2023-09-26 | Nusirt Sciences, Inc. | Leucine and nicotinic acid reduces lipid levels |
GB201313465D0 (en) * | 2013-07-29 | 2013-09-11 | Queens University Of The Belfast | Methods of preparing nicotinamide riboside and derivatives thereof |
JP6507158B2 (ja) | 2013-10-24 | 2019-04-24 | ザ プロクター アンド ギャンブル カンパニー | 皮膚を明るくする化粧組成物 |
WO2015064988A1 (ko) | 2013-10-29 | 2015-05-07 | 한림대학교 산학협력단 | 니코틴아마이드 라이보사이드를 유효성분으로 포함하는 패혈증 치료 또는 예방용 약제학적 조성물 |
KR20220098049A (ko) | 2013-10-30 | 2022-07-08 | 크로마덱스 아이엔씨. | 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 |
CA2929666C (en) | 2013-11-12 | 2023-08-01 | Ortho-Nutra, Llc | Theacrine-based supplement and method of use thereof |
WO2015099842A1 (en) | 2013-12-23 | 2015-07-02 | Abbott Laboratories | Hot beverage fortifier |
KR20160133529A (ko) | 2014-03-13 | 2016-11-22 | 더 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 펙사라민 유도체 및 이의 제조와 사용 방법 |
WO2015138986A1 (en) | 2014-03-13 | 2015-09-17 | Salk Institute For Biological Studies | Fxr agonists and methods for making and using |
US20150297508A1 (en) | 2014-04-21 | 2015-10-22 | William Andriette | Topical Formulation to Enhance Genital Sensation and Function |
KR20170012449A (ko) * | 2014-06-02 | 2017-02-02 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 결정질 베타-d-니코틴아미드 리보시드의 제조 및 용도 |
KR20170008320A (ko) | 2014-06-06 | 2017-01-23 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 니코틴아미드 리보시드 유사체 및 그의 제약 조성물 및 용도 |
US20170202822A1 (en) | 2014-07-17 | 2017-07-20 | The Scripps Research Institute | Methods and compositions for enhancing cancer therapy |
US10189872B2 (en) | 2015-03-09 | 2019-01-29 | W. R. Grace & Co.-Conn | Crystalline form of nicotinamide riboside |
-
2015
- 2015-07-24 PL PL15825253T patent/PL3174891T3/pl unknown
- 2015-07-24 ES ES15825253T patent/ES2776395T3/es active Active
- 2015-07-24 CA CA2956163A patent/CA2956163C/en active Active
- 2015-07-24 WO PCT/US2015/041956 patent/WO2016014927A2/en active Application Filing
- 2015-07-24 CN CN201580051724.1A patent/CN106715454B/zh active Active
- 2015-07-24 EP EP20153772.7A patent/EP3670522B1/en active Active
- 2015-07-24 US US15/328,664 patent/US10323058B2/en active Active
- 2015-07-24 EP EP15825253.6A patent/EP3174891B1/en active Active
- 2015-07-24 PL PL20153772T patent/PL3670522T3/pl unknown
- 2015-07-24 ES ES20153772T patent/ES2908332T3/es active Active
-
2017
- 2017-10-23 US US15/791,097 patent/US10233207B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2908332T3 (es) | 2022-04-28 |
EP3174891A4 (en) | 2018-05-30 |
EP3670522A1 (en) | 2020-06-24 |
US10323058B2 (en) | 2019-06-18 |
CN106715454A (zh) | 2017-05-24 |
EP3174891A2 (en) | 2017-06-07 |
US20170210774A1 (en) | 2017-07-27 |
US10233207B2 (en) | 2019-03-19 |
ES2776395T3 (es) | 2020-07-30 |
EP3670522B1 (en) | 2022-01-19 |
CN106715454B (zh) | 2020-06-16 |
CA2956163A1 (en) | 2016-01-28 |
WO2016014927A2 (en) | 2016-01-28 |
CA2956163C (en) | 2023-01-10 |
US20180086783A1 (en) | 2018-03-29 |
EP3174891B1 (en) | 2020-01-29 |
PL3670522T3 (pl) | 2022-02-21 |
WO2016014927A3 (en) | 2016-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247726A1 (zh) | 烟酰胺核苷的結晶形式 | |
PL3174891T3 (pl) | Krystaliczna postać rybozydu nikotynamidu | |
IL251560A0 (en) | Methods for preparing ribosides | |
EP3136857A4 (en) | Crystalline form of baricitinib | |
HK1252845A1 (zh) | 勞拉替尼游離碱的結晶形式 | |
IL246385B (en) | Crystalline forms of efitinib di-malate | |
HK1255112A1 (zh) | 吉西他濱的晶型 | |
SI3380554T2 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
HK1244274A1 (zh) | C21h22ci2n4o2的晶型 | |
IL246979A0 (en) | Crystalline forms of sofosbuvir | |
IL253479A0 (en) | Crystalline forms of efinconazole | |
PT3113773T (pt) | Formas cristalinas do grapiprant | |
IL251863A0 (en) | Crystalline forms of ferric-maltol | |
EP3207034A4 (en) | Anhydrous crystalline form of s-equol | |
HK1255148A1 (zh) | 結晶形式 | |
HUP1500506A2 (en) | Salts of palbociclib | |
IL249332A0 (en) | Crystalline forms of sofosbuvir |